Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director · president and CEO | September 28, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 66,418 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Sale · Disposed 2,000 · Balance 66,418 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Nov 16, 2021 15:37 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $500.54 | $1,501,620.00 |
DisclosureSEC source: 0001209191-21-064629 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,472 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $498.20 to $504.61. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 15:16 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 26,000 | $231.91 Strike: $231.91 | $6,029,660.00 |
DisclosureSEC source: 0001209191-21-062606 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,327 Underlying: capital stock · 26,000 shares Expires 2022-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018 Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 15:16 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 6,000 | $485.06 | $2,910,360.00 |
DisclosureSEC source: 0001209191-21-062606 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,472 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $482.99 to $486.59. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 15:16 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 18,216 | $487.06 | $8,872,284.96 |
DisclosureSEC source: 0001209191-21-062606 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,472 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 15:16 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 26,000 | $231.91 | $6,029,660.00 |
DisclosureSEC source: 0001209191-21-062606 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 17:26 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 36,803 | $445.35 Strike: $445.35 | $16,390,216.05 |
DisclosureSEC source: 0001209191-21-062311 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,327 Underlying: capital stock · 36,803 shares Expires 2026-10-28 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 14:23 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $467.78 | $1,403,340.00 |
DisclosureSEC source: 0001209191-21-050524 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,688 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $467.00 to $469.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 20:15 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $497.61 | $1,492,830.00 |
DisclosureSEC source: 0001209191-21-038574 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,688 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.01 to $499.10. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 05, 2021 Filed May 6, 2021 17:48 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 4,000 | $231.91 Strike: $231.91 | $927,640.00 |
DisclosureSEC source: 0001209191-21-030565 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,524 Underlying: capital stock · 4,000 shares Expires 2022-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018 Read SEC document |
| May 05, 2021 Filed May 6, 2021 17:48 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $477.37 | $1,432,110.00 |
DisclosureSEC source: 0001209191-21-030565 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,688 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $469.72 to $483.19. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 05, 2021 Filed May 6, 2021 17:48 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 2,809 | $484.12 | $1,359,893.08 |
DisclosureSEC source: 0001209191-21-030565 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,688 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 05, 2021 Filed May 6, 2021 17:48 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 4,000 | $231.91 | $927,640.00 |
DisclosureSEC source: 0001209191-21-030565 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:30 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 3,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013124 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,080 Underlying: capital stock · 3,474 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2021 to December 31, 2023. The determination of the performance level is to be made by March 15, 2024 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2021 to December 31, 2023. The determination of the performance level is to be made by March 15, 2024 and earned shares to be delivered thereafter. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:30 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 1,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013124 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606 Underlying: capital stock · 1,964 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 16, 2018 vest based on achievement of performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level was to be made by March 15, 2021. F5 · derivative.expiration_date: PSU's awarded February 16, 2018 vest based on achievement of performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level was to be made by March 15, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:30 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 1,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013124 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,570 Underlying: capital stock · 1,964 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 16, 2018 vest based on achievement of performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level was to be made by March 15, 2021. F5 · derivative.expiration_date: PSU's awarded February 16, 2018 vest based on achievement of performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level was to be made by March 15, 2021. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:30 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,217 | $491.34 | $1,580,640.78 |
DisclosureSEC source: 0001209191-21-013124 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,497 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:30 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,237 | $491.34 | $1,590,467.58 |
DisclosureSEC source: 0001209191-21-013124 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2018 through December 31, 2020, compared to a defined peer group of companies. The Company's performance ranked in the 79th percentile of that group, yielding an award of 163.2%; including the reinvestment of dividends paid during such period, the award is 164.79% of target. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 20:30 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,967 | $491.34 | $1,949,145.78 |
DisclosureSEC source: 0001209191-21-013124 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2018 through December 31, 2020. The actual performance of 29.1% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target. Read SEC document |
| January 08, 2021 Filed Jan 11, 2021 16:48 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,000 | $549.30 | $1,098,600.00 |
DisclosureSEC source: 0001209191-21-002871 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,510 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.10 to $553.86. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 16:48 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 10,000 | $231.91 Strike: $231.91 | $2,319,100.00 |
DisclosureSEC source: 0001209191-21-002871 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,524 Underlying: capital stock · 10,000 shares Expires 2022-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018 Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 16:48 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 6,453 | $545.49 | $3,520,046.97 |
DisclosureSEC source: 0001209191-21-002871 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,510 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 16:48 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 10,000 | $231.91 | $2,319,100.00 |
DisclosureSEC source: 0001209191-21-002871 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2020 Filed Dec 30, 2020 16:57 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 2,500 | $525.50 | $1,313,750.00 |
DisclosureSEC source: 0001209191-20-065462 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,963 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.00 to $526.52. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 19:14 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 4,000 | $485.13 | $1,940,520.00 |
DisclosureSEC source: 0001209191-20-057574 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,463 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $478.19 to $496.78. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (1) to this Form 4. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 21:27 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 15,000 | $231.91 Strike: $231.91 | $3,478,650.00 |
DisclosureSEC source: 0001209191-20-057287 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,524 Underlying: capital stock · 15,000 shares Expires 2022-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018 Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 21:27 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 4,500 | $499.31 | $2,246,895.00 |
DisclosureSEC source: 0001209191-20-057287 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,463 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $493.76 to $508.26. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (2) to this Form 4. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 21:27 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 10,329 | $509.60 | $5,263,658.40 |
DisclosureSEC source: 0001209191-20-057287 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,963 F1 · shares: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 21:27 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 15,000 | $231.91 | $3,478,650.00 |
DisclosureSEC source: 0001209191-20-057287 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 16:39 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 41,224 | $471.74 Strike: $471.74 | $19,447,009.76 |
DisclosureSEC source: 0001209191-20-056298 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,524 Underlying: capital stock · 41,224 shares Expires 2025-10-29 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021 Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 14:48 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 15,800 | $135.85 Strike: $135.85 | $2,146,430.00 |
DisclosureSEC source: 0001209191-20-045416 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,300 Underlying: capital stock · 15,800 shares Expires 2021-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 14:48 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 8,000 | $500.39 | $4,003,120.00 |
DisclosureSEC source: 0001209191-20-045416 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,292 Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 14:48 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 9,235 | $497.78 | $4,596,998.30 |
DisclosureSEC source: 0001209191-20-045416 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,292 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 14:48 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 15,800 | $135.85 | $2,146,430.00 |
DisclosureSEC source: 0001209191-20-045416 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2020 Filed May 27, 2020 15:09 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,000 | $483.98 | $2,419,900.00 |
DisclosureSEC source: 0001209191-20-032225 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,727 Read SEC document |
| May 13, 2020 Filed May 15, 2020 18:12 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 7,000 | $431.36 | $3,019,520.00 |
DisclosureSEC source: 0001209191-20-029648 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,727 Read SEC document |
| May 06, 2020 Filed May 6, 2020 15:35 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $135.85 Strike: $135.85 | $4,075,500.00 |
DisclosureSEC source: 0001209191-20-027408 · doc4.xml · derivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,100 Underlying: capital stock · 30,000 shares Expires 2021-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Payment of purchase price and tax obligation on stock option exercise. F2 · derivative.expiration_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| May 06, 2020 Filed May 6, 2020 15:35 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 18,350 | $423.83 | $7,777,280.50 |
DisclosureSEC source: 0001209191-20-027408 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,727 Read SEC document |
| May 06, 2020 Filed May 6, 2020 15:35 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,000 | $135.85 | $4,075,500.00 |
DisclosureSEC source: 0001209191-20-027408 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 2,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012363 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,534 Underlying: capital stock · 2,678 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2020 to December 31, 2022. The determination of the performance level is to be made by March 15, 2023 and earned shares to be delivered thereafter. F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2020 to December 31, 2022. The determination of the performance level is to be made by March 15, 2023 and earned shares to be delivered thereafter. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 2,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012363 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,856 Underlying: capital stock · 2,157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. F5 · derivative.expiration_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 2,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012363 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,013 Underlying: capital stock · 2,157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. F5 · derivative.expiration_date: PSU's awarded February 17, 2017 vest based on achievement of performance targets over a period of January 1, 2017 to December 31, 2019. The determination of the performance level was to be made by March 15, 2020. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 3,566 | $487.90 | $1,739,851.40 |
DisclosureSEC source: 0001209191-20-012363 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,077 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,563 | $487.90 | $1,738,387.70 |
DisclosureSEC source: 0001209191-20-012363 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2017 through December 31, 2019, compared to a defined peer group of companies. The Company's performance ranked in the 79th percentile of that group, yielding an award of 163.2%; including the reinvestment of dividends paid during such period, the award is 165.2% of target. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:53 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 4,368 | $487.90 | $2,131,147.20 |
DisclosureSEC source: 0001209191-20-012363 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2017 through December 31, 2019. The actual performance of 24.29% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.5% of target. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 15:50 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 43,700 | $413.19 Strike: $413.19 | $18,056,403.00 |
DisclosureSEC source: 0001209191-19-054592 · doc4.xml · derivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,100 Underlying: capital stock · 43,700 shares Expires 2024-10-29 F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020 Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 15:50 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,000 | $432.73 | $2,163,650.00 |
DisclosureSEC source: 0001209191-19-047233 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,712 Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 15:36 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 40,000 | $135.85 Strike: $135.85 | $5,434,000.00 |
DisclosureSEC source: 0001209191-19-045070 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,400 Underlying: capital stock · 40,000 shares Expires 2021-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 15:36 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 24,606 | $415.97 | $10,235,357.82 |
DisclosureSEC source: 0001209191-19-045070 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,712 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 08, 2019 Filed Aug 8, 2019 15:36 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 40,000 | $135.85 | $5,434,000.00 |
DisclosureSEC source: 0001209191-19-045070 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 15:36 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 12,000 | $416.80 | $5,001,600.00 |
DisclosureSEC source: 0001209191-19-045070 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,318 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.